Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.12
+0.52 (2.20%)
At close: Mar 4, 2026, 4:00 PM EST
24.12
0.00 (0.00%)
After-hours: Mar 4, 2026, 4:43 PM EST
Arcutis Biotherapeutics Employees
Arcutis Biotherapeutics had 354 employees as of December 31, 2025. The number of employees increased by 12 or 3.51% compared to the previous year.
Employees
354
Change (1Y)
12
Growth (1Y)
3.51%
Revenue / Employee
$1,062,350
Profits / Employee
-$45,596
Market Cap
2.99B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 354 | 12 | 3.51% |
| Dec 31, 2024 | 342 | 46 | 15.54% |
| Dec 31, 2023 | 296 | 28 | 10.45% |
| Dec 31, 2022 | 268 | 121 | 82.31% |
| Dec 31, 2021 | 147 | 93 | 172.22% |
| Sep 30, 2021 | 143 | 90 | 169.81% |
| Jun 30, 2021 | 108 | 59 | 120.41% |
| Mar 31, 2021 | 75 | 32 | 74.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Arcus Biosciences | 601 |
| Beam Therapeutics | 511 |
| Denali Therapeutics | 503 |
| Tarsus Pharmaceuticals | 370 |
| Vera Therapeutics | 224 |
| Catalyst Pharmaceuticals | 182 |
| Liquidia | 170 |
| Edgewise Therapeutics | 146 |
ARQT News
- 1 day ago - Baron Health Care Fund Q4 2025 Recent Activity - Seeking Alpha
- 1 day ago - Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis - GlobeNewsWire
- 5 days ago - Arcutis Management to Present at TD Cowen's 46th Annual Health Care Conference - GlobeNewsWire
- 6 days ago - Arcutis Earnings: Zoryve Dominance And Pipeline Catalysts Drive The Bull Case - Seeking Alpha
- 6 days ago - Arcutis Biotherapeutics, Inc. (ARQT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Arcutis Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 8 days ago - Professional Golfer Max Homa Joins Arcutis' Free to Be Me Campaign, Urging Individuals with Seborrheic Dermatitis to Tee Up a Conversation with Their Healthcare Provider About Long-Term Treatments - GlobeNewsWire
- 12 days ago - Arcutis After The Double: Hypergrowth Peaks, Compounding Remains - Seeking Alpha